Cardiovascular safety and efficacy of vadadustat for the treatment of anemia in non-dialysis-dependent CKD: Design and baseline characteristics.
第一作者:
Glenn M,Chertow
第一单位:
Stanford University School of Medicine, Stanford, CA. Electronic address: gchertow@stanford.edu.
作者:
医学主题词
投药, 口服(Administration, Oral);老年人(Aged);贫血(Anemia);女(雌)性(Female);随访研究(Follow-Up Studies);甘氨酸(Glycine);人类(Humans);男(雄)性(Male);中年人(Middle Aged);吡啶羧酸类(Picolinic Acids);肾透析(Renal Dialysis);肾功能不全, 慢性(Renal Insufficiency, Chronic);治疗结果(Treatment Outcome);临床试验, Ⅲ期(主题)(Clinical Trials, Phase III as Topic);多中心研究(主题)(Multicenter Studies as Topic)
DOI
10.1016/j.ahj.2020.10.068
PMID
33129989
发布时间
2026-01-05
- 浏览0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文


换一批



